The stem cell-transplant technology developer, partly based on Stanford research, is going public through a reverse merger that will give it a $490m market capitalisation.

Roche Venture Fund and Amgen will invest in the stem cell-transplant technology developer through a reverse merger transaction which will give it a $490m market capitalisation.

The Sanofi, Amgen, Alphabet, Novartis and PPD-backed clinical trials software producer is joining forces with publicly listed LifeSci Acquisition II Corp.

Hanaco and PayPal are set to exit Divvy, a provider of corporate spend management software, at a 56% premium to the valuation at which they invested in January.

Tekfen Ventures, Cisco Investments and Qualcomm Ventures are set to exit the crop monitoring technology developer later this year in a deal with Valmont Industries.

The SK Telecom-backed app advertising and monetisation service provider is set to be bought by Zynga following $21m of venture funding.

The Chernin Group is set to exit the sports betting news platform provider it extablished four years ago, in a $240m acquisition deal.

Bitmain and DRW subsidiary Cumberland Mining are set to exit the crypto finance software provider five years after their investment.

Opioid addiction care provider Groups Recover Together and healthcare management platform developer Vim each raised $60m, with Optum Ventures backing both rounds.

BitFury is set to exit the crypto wallet developer through a cash-and-stock acquisition by another investor, Galaxy Digital Holdings.